• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌患者外周血中辅助性T细胞17(TH17)细胞的患病率增加。

Increased prevalence of T(H)17 cells in the peripheral blood of patients with head and neck squamous cell carcinoma.

作者信息

Li Chen, Zhao Yifang, Zhang Wenfeng, Zhang Wei

机构信息

State Key Laboratory Breeding Base of Basic Science of Stomatology, Ministry of Education, Wuhan University, Wuhan, China.

出版信息

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Jul;112(1):81-9. doi: 10.1016/j.tripleo.2010.11.032. Epub 2011 Mar 31.

DOI:10.1016/j.tripleo.2010.11.032
PMID:21458322
Abstract

OBJECTIVE

This study was performed to determine whether T(H)17 cells are involved in the development and metastasis of head and neck squamous cell carcinomas (HNSCCs).

STUDY DESIGN

T(H)17 cells frequencies in 67 HNSCC patients and 21 healthy volunteers were examined by flow cytometric analysis. T(H)17 cell-related cytokines in serum (interleukin (IL) 17, transforming growth factor (TGF) β, and IL-6) were evaluated by using enzyme-linked immunosorbent assay.

RESULTS

It was discovered that the higher frequency of T(H)17 cells was in HNSCCs patients (1.0 ± 0.4%). The cell proportions and related cytokine concentrations were consistent with the tumor TNM stage. The IL-6 concentration showed positive correlation with the frequency of T(H)17 cells (r = 0.661) and IL-17 levels (r = 0.597). The TGF-β concentration showed a positive correlation with IL-17 (r = 0.626) but no relationship with T(H)17 cells (r = 0.431).

CONCLUSIONS

The present data suggested that T(H)17 cells may be involved in tumor growth and metastasis of HNSCCs. IL-6 may play an important role in T(H)17 cell differentiation and functions, and TGF-β may be related to IL-17 secretion but not to the differentiation of T(H)17 cells.

摘要

目的

本研究旨在确定辅助性T细胞17(Th17)是否参与头颈部鳞状细胞癌(HNSCC)的发生发展及转移。

研究设计

采用流式细胞术分析检测67例HNSCC患者和21名健康志愿者体内Th17细胞的频率。采用酶联免疫吸附测定法评估血清中Th17细胞相关细胞因子(白细胞介素(IL)-17、转化生长因子(TGF)-β和IL-6)。

结果

发现HNSCC患者体内Th17细胞频率较高(1.0±0.4%)。细胞比例及相关细胞因子浓度与肿瘤TNM分期一致。IL-6浓度与Th17细胞频率(r = 0.661)和IL-17水平(r = 0.597)呈正相关。TGF-β浓度与IL-17呈正相关(r = 0.626),但与Th17细胞无相关性(r = 0.431)。

结论

目前的数据表明,Th17细胞可能参与HNSCC的肿瘤生长和转移。IL-6可能在Th17细胞分化和功能中起重要作用,而TGF-β可能与IL-17分泌有关,但与Th17细胞分化无关。

相似文献

1
Increased prevalence of T(H)17 cells in the peripheral blood of patients with head and neck squamous cell carcinoma.头颈部鳞状细胞癌患者外周血中辅助性T细胞17(TH17)细胞的患病率增加。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Jul;112(1):81-9. doi: 10.1016/j.tripleo.2010.11.032. Epub 2011 Mar 31.
2
Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.原发性头颈部鳞状细胞癌患者的血清白细胞介素-6水平。
Anticancer Res. 2005 Jul-Aug;25(4):2761-5.
3
Identification of the peripheral blood levels of interleukin-12, interleukin-10, and transforming growth factor-β in patients with laryngeal squamous cell carcinoma.检测喉鳞状细胞癌患者外周血中白细胞介素-12、白细胞介素-10 和转化生长因子-β的水平。
Head Neck. 2012 Mar;34(3):393-7. doi: 10.1002/hed.21738. Epub 2011 Apr 5.
4
Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.口腔鳞状细胞癌患者血管内皮生长因子的循环水平。
Int J Oral Maxillofac Surg. 2002 Oct;31(5):495-8. doi: 10.1054/ijom.2002.0284.
5
Role of interleukin-10 and transforming growth factor beta 1 in otitis media with effusion.白细胞介素-10 和转化生长因子-β1 在分泌性中耳炎中的作用。
Chin Med J (Engl). 2009 Sep 20;122(18):2149-54.
6
Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.头颈癌患者促炎和促血管生成细胞因子的表达
Clin Cancer Res. 1999 Jun;5(6):1369-79.
7
Th1 and Th17 Predominance in the Enthesitis-related Arthritis Form of Juvenile Idiopathic Arthritis.青少年特发性关节炎的附着点炎相关关节炎形式中Th1和Th17占主导地位。
J Rheumatol. 2009 Aug;36(8):1730-6. doi: 10.3899/jrheum.081179. Epub 2009 Jun 16.
8
Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.头颈部癌症患者白细胞介素10、12和18水平的研究。
J Laryngol Otol. 2007 Mar;121(3):246-52. doi: 10.1017/S0022215106002428. Epub 2006 Aug 15.
9
Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.环氧合酶2过表达的头颈部鳞状细胞癌微环境中人类1型调节性T细胞的扩增
Cancer Res. 2007 Sep 15;67(18):8865-73. doi: 10.1158/0008-5472.CAN-07-0767.
10
Profile of Th17 cytokines (IL-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura.免疫性血小板减少性紫癜患者中Th17细胞因子(白细胞介素-17、转化生长因子-β、白细胞介素-6)和Th1细胞因子(干扰素-γ)的概况
Ann Hematol. 2008 Nov;87(11):899-904. doi: 10.1007/s00277-008-0535-3. Epub 2008 Jul 4.

引用本文的文献

1
Construction of a prognostic signature based on T-helper 17 cells differentiation-related genes for predicting survival and tumor microenvironment in head and neck squamous cell carcinoma.基于辅助性T细胞17分化相关基因构建预测头颈部鳞状细胞癌生存及肿瘤微环境的预后特征。
Medicine (Baltimore). 2025 Jan 24;104(4):e41273. doi: 10.1097/MD.0000000000041273.
2
Act1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis.Act1 通过调节抗氧化 RNA 代谢和氧化还原平衡来驱动化疗耐药性。
J Exp Med. 2024 Jul 1;221(7). doi: 10.1084/jem.20231442. Epub 2024 Jun 11.
3
Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment.
通过肿瘤微环境的免疫调节来改善头颈部癌症的治疗方法。
Nat Rev Cancer. 2023 Mar;23(3):173-188. doi: 10.1038/s41568-022-00531-9. Epub 2022 Dec 1.
4
IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives.白细胞介素-6 在头颈部癌症生态系统中的作用:可能的治疗前景。
Int J Mol Sci. 2021 Oct 13;22(20):11027. doi: 10.3390/ijms222011027.
5
A review on the advances and challenges of immunotherapy for head and neck cancer.头颈部癌免疫治疗的进展与挑战综述
Cancer Cell Int. 2021 Jul 31;21(1):406. doi: 10.1186/s12935-021-02024-5.
6
Association Between Interleukin-6 and Head and Neck Squamous Cell Carcinoma: A Systematic Review.白细胞介素-6与头颈部鳞状细胞癌的关联:一项系统综述。
Clin Exp Otorhinolaryngol. 2021 Feb;14(1):50-60. doi: 10.21053/ceo.2019.00906. Epub 2021 Feb 1.
7
Salivary IL-17A, IL-17F, and TNF- Are Associated with Disease Advancement in Patients with Oral and Oropharyngeal Cancer.唾液中白介素-17A、白介素-17F 和肿瘤坏死因子与口腔和口咽癌患者的疾病进展相关。
J Immunol Res. 2020 Aug 13;2020:3928504. doi: 10.1155/2020/3928504. eCollection 2020.
8
Neutrophil extracellular traps enhance procoagulant activity in patients with oral squamous cell carcinoma.中性粒细胞胞外诱捕网增强口腔鳞状细胞癌患者的促凝活性。
J Cancer Res Clin Oncol. 2019 Jul;145(7):1695-1707. doi: 10.1007/s00432-019-02922-2. Epub 2019 Apr 24.
9
Transforming growth factor-β signaling in head and neck squamous cell carcinoma: Insights into cellular responses.头颈部鳞状细胞癌中的转化生长因子-β信号传导:对细胞反应的见解
Oncol Lett. 2018 Oct;16(4):4799-4806. doi: 10.3892/ol.2018.9319. Epub 2018 Aug 17.
10
HNSCC subverts PBMCs to secrete soluble products that promote tumor cell proliferation.头颈部鳞状细胞癌(HNSCC)会使外周血单核细胞(PBMCs)分泌促进肿瘤细胞增殖的可溶性产物。
Oncotarget. 2017 Jun 15;8(37):60860-60874. doi: 10.18632/oncotarget.18486. eCollection 2017 Sep 22.